The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

12 Aug 2022 15:30

RNS Number : 9118V
Byotrol PLC
12 August 2022
 

 

 

 

12 August 2022

 

Byotrol plc

("Byotrol" or the "Company")

 

Director Dealing

 

 

Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene technologies, announces that Dr. Trevor Francis, Non-Executive Director of the Company, has transferred, in aggregate, £150,000 of convertible loan notes ("Loan Notes") to his non-dependent children, at par value. These Loan Notes were part of the convertible loan note fundraising announced by the Company on 28 July 2022 and, if converted, would represent approximately 4,615,385 ordinary shares in the capital of the Company.

 

 

Byotrol Plc

David Traynor - Chief Executive Officer

+44 (0)1925 742 000

Chris Sedwell - Chief Financial Officer

finnCap Limited (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Geoff Nash/James Thompson - Corporate Finance

Richard Chambers - ECM

Flagstaff Strategic and Investor Communications

+44 (0)20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

byotrol@flagstaffcomms.com

 

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading infection prevention and control company, operating globally in the animal health, human health, facilities management, and consumer sectors.

 

Byotrol develops unique antimicrobial technologies for use on surfaces, skin and instruments, which it then commercialises through market-leading distribution partners in each sector.

 

Byotrol's antimicrobial technologies can be licensed for use in leading brands, to significantly improve their product claims, while reassuring consumers and end-users of their efficacy and quality.

 

Founded in 2005, the Company develops technologies and products with the aim of providing easier, safer and cleaner lives for everyone. 

 

 

 

 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Trevor Francis

2. 

Reason for the notification

a)

Position/status:

Non-Executive Director

b)

Initial notification/Amendment:

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Byotrol plc

b)

LEI:

213800AJMTSTIPA59A34

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Convertible loan notes over ordinary shares of 0.25 pence per share

GB00B0999995

b)

Nature of the transaction:

Transfer of Convertible Loan Notes

c)

Price(s) and volume(s):

Price(s)

Volume(s)

3.25

4,615,385

d)

Aggregated information:

·Aggregated volume:

·Price:

See 4c) above

 

e)

Date of the transaction:

12/08/2022

f)

Place of the transaction:

Off Market Transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGMRDZLGZZM
Date   Source Headline
5th Aug 20097:00 amRNSUpdate on current business
30th Jul 20094:46 pmRNSResult of AGM
9th Jul 20098:07 amRNSAnnual Report & Accounts
30th Jun 20094:37 pmRNSHolding(s) in Company
24th Jun 20099:29 amRNSDirector/PDMR Shareholding
23rd Jun 20094:57 pmRNSDirector/PDMR Shareholding
22nd Jun 20098:00 amRNSDirectorate Change
16th Jun 20097:00 amRNSFinal Results
11th May 20097:00 amRNSDirectorate Change
2nd Mar 20098:00 amRNSUpdate on Trading
28th Nov 200810:58 amRNSTotal Voting Rights
25th Nov 20081:52 pmRNSHolding(s) in Company
25th Nov 20081:51 pmRNSHolding(s) in Company
24th Nov 20081:20 pmRNSHolding(s) in Company
24th Nov 20087:00 amRNSInterim Results
20th Nov 20083:32 pmRNSHolding(s) in Company
20th Nov 200812:28 pmRNSHolding(s) in Company
19th Nov 200810:30 amRNSResult of EGM
31st Oct 20087:00 amRNSConfirmation of posting of Circular
30th Oct 20087:30 amRNSNHS Supply Chain Listing
29th Oct 200812:00 pmRNSProposed Placing / Notice of General Meeting
7th Oct 20087:00 amRNSHealthcare Update
30th Sep 200810:46 amRNSTotal Voting Rights
5th Sep 200812:00 pmRNSHolding(s) in Company
1st Sep 200811:14 amRNSDirector/PDMR Shareholding
29th Aug 20089:00 amRNSTotal Voting Rights
21st Aug 200812:37 pmRNSHolding(s) in Company Replace
20th Aug 200812:00 pmRNSHolding(s) in Company
18th Aug 20087:00 amRNSDirector/PDMR Shareholding
6th Aug 200812:18 pmRNSDirector/PDMR Shareholding
31st Jul 20083:09 pmRNSResult of AGM
18th Jul 20087:54 amRNSDirector/PDMR Shareholding
16th Jul 20087:53 amRNSDirector/PDMR Shareholding
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
4th Jul 20083:00 pmRNSAnnual Report and Accounts
3rd Jul 20084:49 pmRNSHolding(s) in Company
2nd Jul 20084:00 pmRNSHolding(s) in Company
27th Jun 20088:50 amRNSHolding(s) in Company
17th Jun 20087:00 amRNSFinal Results
29th May 20081:50 pmRNSResult of Meeting
27th Feb 20087:02 amRNSLatest developments
13th Feb 20088:57 amRNSHolding(s) in Company
5th Feb 20081:19 pmRNSHolding(s) in Company
11th Jan 200812:52 pmRNSHolding(s) in Company
19th Dec 200712:22 pmRNSHolding(s) in Company
29th Nov 20077:01 amRNSInterim Results
28th Sep 200712:02 pmRNSTotal Voting Rights
25th Sep 20073:19 pmRNSHolding(s) in Company
18th Sep 20074:50 pmRNSAdditional Listing
6th Sep 20074:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.